Literature DB >> 22689731

Pancreatic ascites in the setting of portal hypertension.

Zohaib Farooque Shaikh1, Gajanan Kulsundar, Makardhwaj Sarvadaman Shrivastava, Vishal Vasant Ramteke, Sameer Yadav, Nivedita Moulick.   

Abstract

Pancreatic ascites is a rare cause of ascites and develops largely as a complication of chronic pancreatitis or sometimes due to duct injury during surgical procedures. The entity may mimic spontaneous bacterial peritonitis or ascites due to portal hypertension. Here, the authors discuss a case of pancreatic ascites developing in the setting of alcoholic liver disease with portal hypertension. The patient had features of chronic pancreatitis with pancreatic duct fistula and was managed with stenting of the pancreatic duct.

Entities:  

Mesh:

Year:  2011        PMID: 22689731      PMCID: PMC3149431          DOI: 10.1136/bcr.08.2010.3271

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  5 in total

1.  Pancreatic ascites: rare complication of a common disease.

Authors:  S C Chaudhary; R Avasthi; D Mohanty; P Jain
Journal:  J Assoc Physicians India       Date:  2009-02

2.  Pancreatic ascites and effusion. Risk factors for failure of conservative therapy and the role of octreotide.

Authors:  D Parekh; I Segal
Journal:  Arch Surg       Date:  1992-06

3.  Endoscopic pancreatic duct stenting to treat pancreatic ascites.

Authors:  G A Bracher; A P Manocha; J R DeBanto; L K Gates; A Slivka; D C Whitcomb; B L Bleau; C D Ulrich; S P Martin
Journal:  Gastrointest Endosc       Date:  1999-06       Impact factor: 9.427

4.  Pancreatic ascites: treatment by continuous somatostatin infusion.

Authors:  H Gislason; J E Grønbech; O Søreide
Journal:  Am J Gastroenterol       Date:  1991-04       Impact factor: 10.864

5.  Pancreatic ascites: study of therapeutic options by analysis of case reports and case series between the years 1975 and 2000.

Authors:  J Gómez-Cerezo; A Barbado Cano; I Suárez; A Soto; J J Ríos; J J Vázquez
Journal:  Am J Gastroenterol       Date:  2003-03       Impact factor: 10.864

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.